Flamingo Therapeutics

About:

Flamingo Therapeutics is pioneering RNA-targeted therapies for oncology.

Website: https://flamingotx.com/

Top Investors: Agentschap Innoveren & Ondernemen

Description:

Flamingo Therapeutics is pioneering RNA-targeted therapies for oncology.

Total Funding Amount:

1.7M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Leuven, Vlaams-Brabant, Belgium

Founded Date:

2020-01-01

Contact Email:

hello(AT)flamingotx.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2023-06-15

IPO Status:

Private

Industries: